Journal
JOURNAL OF PHARMACY AND PHARMACOLOGY
Volume 53, Issue 7, Pages 935-938Publisher
ROYAL PHARMACEUTICAL SOC GREAT BRITAIN
DOI: 10.1211/0022357011776333
Keywords
-
Categories
Ask authors/readers for more resources
In the fight against malaria, chemotherapy using bisacridines may represent an alternative method to overcoming chloroquine-resistance. Eight bis(9-amino-6-chloro-2-methoxyacridines), in which acridine moieties were linked by polyamines substituted with a side chain, were tested for their in-vivo activity upon mice infected by Plasmodium berghei. Three of the compounds revealed antimalarial activity but no relationship could be deduced from a comparison of in-vitro and in-vivo activities. N-alkylation of the central amino group generated toxicity and, therefore, only compounds N-acylated in this position can be selected as leads.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available